Ethambutol-associated optic neuropathy.
- Author:
Su-Ann LIM
1
Author Information
- Publication Type:Case Reports
- MeSH: Aged; Antitubercular Agents; adverse effects; Ethambutol; adverse effects; Female; Hemianopsia; chemically induced; Humans; Male; Middle Aged; Optic Nerve Diseases; chemically induced; Tuberculosis; drug therapy
- From:Annals of the Academy of Medicine, Singapore 2006;35(4):274-278
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTIONEthambutol is used in the treatment of tuberculosis, which is still prevalent in Southeast Asia, and can be associated with permanent visual loss. We report 3 cases which presented with bitemporal hemianopia.
CLINICAL PICTUREThree patients with ethambutol-associated toxic optic neuropathy are described. All 3 patients had loss of central visual acuity, colour vision (Ishihara) and visual field. The visual field loss had a bitemporal flavour, suggesting involvement of the optic chiasm.
TREATMENTDespite stopping ethambutol on diagnosis, visual function continued to deteriorate for a few months. Subsequent improvement was mild in 2 cases. In the third case, visual acuity and colour vision normalised but the optic discs were pale.
OUTCOMEAll 3 patients had some permanent loss of visual function.
CONCLUSIONSEthambutol usage is associated with permanent visual loss and should be avoided if possible or used with caution and proper ophthalmological follow-up. The author postulates that in cases of ethambutol associated chiasmopathy, ethambutol may initially affect the optic nerves and subsequently progress to involve the optic chiasm.